Longitudinal Analysis of Plasma Proteomic Alterations After BNT162b2 COVID-19 Booster Vaccination in Qatar - Top-Institutions - MDSpire

Longitudinal Analysis of Plasma Proteomic Alterations After BNT162b2 COVID-19 Booster Vaccination in Qatar

  • By

  • Sana Bentebbal

  • Ahmed Zaqout

  • Bakhita Meqbel

  • Ilham Bensmail

  • Abdullah Aldushain

  • Alberto de la Fuente

  • Remy Thomas

  • Adviti Naik

  • Hibah Shaath

  • Neyla S. Al-Akl

  • Abdi Adam

  • Houda Y. A. Moussa

  • Kyung C. Shin

  • Rowaida Z. Taha

  • Mohammed Abukhattab

  • Muna A. Al-Maslamani

  • Nehad M. Alajez

  • Abdelilah Arredouani

  • Yongsoo Park

  • Sara A. Abdulla

  • Omar M. A. El-Agnaf

  • Houari B. Abdesselem

  • Ali S. Omrani

  • Julie Decock

  • April 24, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Immunology
    • Infectious Diseases
    • Proteomics

  • #2

    Massachusetts General Hospital, Harvard Medical School
    Massachusetts General Hospital, Harvard Medical School

    Boston, MA

    Key Differentiators

    • Immunology
    • Infectious Diseases
    • Clinical Proteomics

  • #3

    The Scripps Research Institute
    The Scripps Research Institute

    La Jolla, CA

    Key Differentiators

    • Immunology
    • Proteomics
    • Vaccine Research

  • #4

    University of Oxford
    University of Oxford

    Oxford, N/A

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Vaccine Development

  • #5

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, N/A

    Key Differentiators

    • Immunology
    • Infectious Diseases
    • Proteomics

Original Source(s)

Longitudinal Analysis of Plasma Proteomic Alterations After BNT162b2 COVID-19 Booster Vaccination in Qatar

  • by Sana Bentebbal, Ahmed Zaqout, Bakhita Meqbel, Ilham Bensmail, Abdullah Aldushain, Alberto de la Fuente, Remy Thomas, Adviti Naik, Hibah Shaath, Neyla S. Al-Akl, Abdi Adam, Houda Y. A. Moussa, Kyung C. Shin, Rowaida Z. Taha, Mohammed Abukhattab, Muna A. Al-Maslamani, Nehad M. Alajez, Abdelilah Arredouani, Yongsoo Park, Sara A. Abdulla, Omar M. A. El-Agnaf, Houari B. Abdesselem, Ali S. Omrani, Julie Decock

  • April 24, 2026

Related Content

Serum cytokine profiling reveals CXCL10 (IP-10) as a major predictor of severe COVID-19 outcomes in hospitalized patients during the first pandemic wave in Italy

Post-acute metabolic changes and risk of new-onset diabetes following COVID-19: a systematic review and meta-analysis

Assessing PEPFAR’s Health Spillover Effects Beyond HIV: An Update